GSK-6340

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameGSK-6340
Drug Alias NameGSK-340GSK-6340
ClassificationSmall molecules
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitorsBromodomain-containing protein 3 inhibitorsBromodomain-containing protein 4 inhibitors
TargetsBromodomain and extra terminal domain proteinBromodomain-containing protein 4Bromodomain-containing protein 3
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of StrathclydeGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A